Kendra Wiley
Family · Lubbock, TXNPI 1205347549
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,191 of the $1,808 with a category attached, or 65.9%. Si-bone, Inc. accounts for 74.9% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $1,498, 9.2 times the $163 reported in 2021.
Across 22 payments — averaging $82.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$1K
- AstraZeneca$116
- Stryker$58
- Vertex$53
- Bioventus LLC$49
- Organogenesis Inc.$48
- plus $131 from 5 others
What the payments were for
- Travel & lodging$1,19166%
- Food & beverage$61734%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 6 | $1,354 |
| AstraZeneca | 1 | $116 |
| Stryker | 1 | $58 |
| Vertex | 2 | $53 |
| Bioventus LLC | 2 | $49 |
| Organogenesis Inc. | 2 | $48 |
| Solventum Corporation | 3 | $47 |
| Smith+Nephew | 2 | $34 |
| Amgen | 1 | $18 |
| Kerecis Limited | 1 | $17 |
| Pacira Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IFUSE IMPLANT SYSTEM$1,162
- BREZTRI$116
How this compares
$1,808 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acetaminophen-CodeineAcetaminophen With Codeine | 58 | $567 |
| Tramadol Hcl | 25 | $127 |
| Gabapentin | 12 | $92 |
Paid to pharmacies, not to this prescriber.
Other family in Lubbock
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.